4//SEC Filing
Van Hoose Kyri K. 4
Accession 0001654954-25-000692
CIK 0001853816other
Filed
Jan 22, 7:00 PM ET
Accepted
Jan 23, 5:03 PM ET
Size
7.6 KB
Accession
0001654954-25-000692
Insider Transaction Report
Form 4
Van Hoose Kyri K.
SVP, CFO
Transactions
- Award
Common Stock
2025-01-21+78,741→ 78,741 total - Award
Warrant (Right to Buy)
2025-01-21+78,741→ 78,741 totalExercise: $1.27→ Common Stock (78,741 underlying)
Footnotes (3)
- [F1]The shares of Common Stock and accompanying Warrant were purchased by the Reporting Person from the Issuer in a private placement, which transaction is exempt from Section 16(b) in accordance with Rule 16b-3(d)(1) promulgated under the Securities Exchange Act of 1934, as amended (the "Exchange Act").
- [F2]The purchase price per share of Common Stock and accompanying Warrant was $1.27.
- [F3]The Warrant will become exercisable beginning on the effective date of stockholder approval of the issuance of the shares of Common Stock issuable upon exercise of the warrants issued in the private placement. The Warrant will expire five years from the effective date of stockholder approval. The Warrant cannot be exercised by the Reporting Person if, after giving effect thereto, the Reporting Person, together with his/her affiliates, would beneficially own, as determined in accordance with Section 13(d) of the Exchange Act, more than 9.99% of the number of shares of the Common Stock outstanding immediately after giving effect to such exercise, subject to certain exceptions.
Documents
Issuer
Dermata Therapeutics, Inc.
CIK 0001853816
Entity typeother
Related Parties
1- filerCIK 0001860885
Filing Metadata
- Form type
- 4
- Filed
- Jan 22, 7:00 PM ET
- Accepted
- Jan 23, 5:03 PM ET
- Size
- 7.6 KB